GC Biopharma Corp. (KRX:006280)
South Korea · Delayed Price · Currency is KRW 131,300
+600 (0.46%)
At close: Nov 4, 2025
GC Biopharma Market Cap
GC Biopharma has a market cap or net worth of 1.5 trillion as of November 5, 2025. Its market cap has decreased by -13.31% in one year.
Market Cap
1.50T
Enterprise Value
2.73T
Revenue
1.79T
Ranking
n/a
PE Ratio
20.39
Stock Price
131,300.00
Market Cap Chart
Since August 29, 1995, GC Biopharma's market cap has increased from 29.09B to 1.50T, an increase of 5,063.95%. That is a compound annual growth rate of 13.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 1.50T | -26.85% |
| Dec 30, 2024 | 2.05T | 43.03% |
| Dec 28, 2023 | 1.43T | -3.09% |
| Dec 29, 2022 | 1.48T | -40.60% |
| Dec 30, 2021 | 2.49T | -46.31% |
| Dec 30, 2020 | 4.63T | 206.42% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.84T |
| ALTEOGEN | 29.36T |
| SK Biopharmaceuticals | 9.42T |
| Yuhan | 8.98T |
| HLB Co., Ltd. | 6.19T |
| Peptron | 6.14T |
| ABL Bio | 5.69T |